Literature DB >> 22688066

Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.

Wanyang Liu1, Toshiaki Hitomi, Hatasu Kobayashi, Kouji H Harada, Akio Koizumi.   

Abstract

Moyamoya disease is an idiopathic vascular disorder of the intracranial arteries. Ring finger 213 (RNF213) was previously identified as the strongest susceptibility gene for moyamoya disease in East Asian people by a genome-wide linkage analysis and exome analysis. The coding variant p.R4810K in RNF213 was strongly associated with moyamoya disease in the Japanese (odds ratio: 338.94, p = 1.05 × 10(-100)) and Korean (odds ratio: 135.63, p = 7.59 × 10(-27)) populations, and much less strongly associated in the Chinese population (odds ratio: 14.70, p = 2.63 × 10(-5)). The present study investigated the distribution of variant p.R4810K in RNF213 in 2,508 participants from East and Southeast Asian countries using a TaqMan probe. p.R4810K was detected at an allele frequency of about 1.00% in 4 of 11 investigated locations in China. In contrast, p.R4810K was detected homogeneously at relatively high frequencies of 1.00-1.72% in all investigated locations in Korea and Japan, including Okinawa. p.R4810K was not detected in Southeast Asian populations. The population susceptible to moyamoya disease was estimated to be 16.16 million people in East Asian countries, including 11.41 million Chinese, 1.36 million Korean, and 3.39 million Japanese people. The number of patients with moyamoya disease, which was estimated at approximately one per 300 carriers of p.R4810K, was considered to be 53,800 in East Asian populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22688066     DOI: 10.2176/nmc.52.299

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  44 in total

1.  Genomewide association study identifies no major founder variant in Caucasian moyamoya disease.

Authors:  Wanyang Liu; S T M L D Senevirathna; Toshiaki Hitomi; Hatasu Kobayashi; Constantin Roder; Roman Herzig; Markus Kraemer; Maurits H J Voormolen; Pavlína Cahová; Boris Krischek; Akio Koizumi
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

2.  Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.

Authors:  Yang Cao; Hatasu Kobayashi; Takaaki Morimoto; Risako Kabata; Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2016-06-30       Impact factor: 3.674

Review 3.  Genetic Risk Factors of Intracranial Atherosclerosis.

Authors:  Minghua Liu; Jose Gutierrez
Journal:  Curr Atheroscler Rep       Date:  2020-05-21       Impact factor: 5.113

4.  Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids.

Authors:  Manuele Piccolis; Laura M Bond; Martin Kampmann; Pamela Pulimeno; Chandramohan Chitraju; Christina B K Jayson; Laura P Vaites; Sebastian Boland; Zon Weng Lai; Katlyn R Gabriel; Shane D Elliott; Joao A Paulo; J Wade Harper; Jonathan S Weissman; Tobias C Walther; Robert V Farese
Journal:  Mol Cell       Date:  2019-03-04       Impact factor: 17.970

Review 5.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

6.  RNF213 variants in a child with PHACE syndrome and moyamoya vasculopathy.

Authors:  Kala F Schilter; Jack E Steiner; Wendy Demos; Mohit Maheshwari; Jeremy W Prokop; Elizabeth Worthey; Beth A Drolet; Dawn H Siegel
Journal:  Am J Med Genet A       Date:  2017-07-07       Impact factor: 2.802

7.  RNF213 gene polymorphism rs9916351 and rs8074015 significantly associated with moyamoya disease in Chinese population.

Authors:  Bin Zhu; Xingju Liu; Xueke Zhen; Xixi Li; Mingfen Wu; Yan Zhang; Zhigang Zhao; Dong Zhang; Jizong Zhao
Journal:  Ann Transl Med       Date:  2020-07

8.  Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.

Authors:  Won-Hyung Kim; Sang-Dae Kim; Myung-Hyun Nam; Jin-Man Jung; Sung-Won Jin; Sung-Kon Ha; Dong-Jun Lim; Hae-Bin Lee
Journal:  Childs Nerv Syst       Date:  2018-10-03       Impact factor: 1.475

9.  The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies.

Authors:  Xun-Sha Sun; Jun Wen; Jiao-Xing Li; Rong Lai; Yu-Fang Wang; Hui-Jiao Liu; Wen-Li Sheng
Journal:  Mol Genet Genomics       Date:  2016-02-05       Impact factor: 3.291

10.  Association of De Novo RNF213 Variants With Childhood Onset Moyamoya Disease and Diffuse Occlusive Vasculopathy.

Authors:  Amélie Pinard; Maximillian D J Fiander; Alana C Cecchi; Andrea L Rideout; Mohamed Azouz; Stuart M Fraser; P Daniel McNeely; Simon Walling; Sarah C Novara; Anna C E Hurst; Dongchuan Guo; Sandhya Parkash; Michael J Bamshad; Deborah A Nickerson; Anthony M Vandersteen; Dianna M Milewicz
Journal:  Neurology       Date:  2021-02-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.